SPHK1 and prostate cancer: LPS induced SphK1 S225 phosphorylation in a Toll-like receptor 4 (TLR4)-dependent manner, causing the translocation of SphK1 to plasma membrane, leading to S1P production and ERK1/2 activation, which were required for prostate cancer cell invasion and metastasis [10].